Sanofi Makes Good On Outsourcing Promise In Deal With Covance
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi agrees to outsource a significant portion of R&D to Covance in a 10-year deal involving payments of $1.2 billion to $2.2 billion.
You may also be interested in...
Takeda Goes Virtual, Splitting Non-oncology Development Between Covance And Quintiles
TOKYO - Takeda Pharmaceuticals has teamed with contract research organizations Covance and Quintiles to move toward a "fully virtual outsourcing model," the company announced Feb. 15
GSK Spins Out Pain Assets, Raises $35.4m
UK-based Convergence's lead asset starts Phase II in neuropathic pain
GSK Spins Out Pain Assets, Raises $35.4m
UK-based Convergence's lead asset starts Phase II in neuropathic pain